The authors explained their reports by the assumption that they were connected to a deficiency or suppression of PTX3, which behaves as an oncosuppressor; for this reason, it can play a role in the development of gastric adenocarcinoma. The gene discussed is PTX3; the disease is gastric adenocarcinoma.